A mathematical model of venous neointimal hyperplasia formation

Theoretical Biology and Medical Modelling

Volumn 5, Issue , 2008, Pages

  Budu Grajdeanu, Paula ^a   Schugart, Richard C ^a   Friedman, Avner ^a   Valentine, Christopher ^b   Agarwal, Anil K ^b   Rovin, Brad H ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; SIGNAL PEPTIDE;

ARTERIOVENOUS FISTULA; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL GRAFT; COMPUTER SIMULATION; EXTRACELLULAR MATRIX; HEMODIALYSIS; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; OXIDATIVE STRESS; PARTIAL DIFFERENTIAL EQUATION; PREDICTION; PROTEIN FUNCTION; PROTEIN SECRETION; SMOOTH MUSCLE FIBER; STENOSIS; SURGICAL INJURY; TURBULENT FLOW; VASCULAR ACCESS; VASCULAR SMOOTH MUSCLE; VEIN ANASTOMOSIS; VEIN DISEASE; BIOLOGICAL MODEL; GRAFT OCCLUSION; HUMAN; HYPERPLASIA; INTIMA; PATHOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; STATISTICAL MODEL; STENOSIS, OCCLUSION AND OBSTRUCTION; THEORETICAL MODEL; VASCULAR PATENCY;

CONSTRICTION, PATHOLOGIC; GRAFT OCCLUSION, VASCULAR; HUMANS; HYPERPLASIA; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; MODELS, THEORETICAL; OXIDATIVE STRESS; RENAL DIALYSIS; TUNICA INTIMA; VASCULAR PATENCY;

EID: 40449133319     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-5-2     Document Type: Article

References (40)

1. Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study. A Asif F Galadean D Merrill G Cherla C Cipleu D Epstein D Roth, Kidney Intl 2005 67 1986 1992 10.1111/j.1523-1755.2005.00299.x
2. Hemodialysis vascular access dysfunction: A cellular and molecular viewpoint. P Roy-Chaudhury V Sukhatme A Cheung, J Am Soc Nephrol 2006 17 1112 1127 10.1681/ASN.2005050615 16565259
3. Vascular access for hemodialysis. S Schwab J Harrington A Singh R Roher S Shohaib R Perrone K Meyer D Beasley, Kidney Int 1999 55 2057 2090 10.1046/j.1523-1755.1999.00409.x
4. Hemodialysis vascular access morbidity. H Feldman S Kobrin A Wasserstein, J Am Soc Nephrol 1999 7 523 535
5. USDRS data report. NIH, NIDDK, Atlas of end-stage renal disease in the United States NIH, Bethesda 2002 63 76
6. Vascular access stenosis: Prospects for prevention and therapy. V Sukhatme, Kidney Int 1996 46 1161 1174 10.1038/ki.1996.167
7. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients: Clinical, immunocytochemical, light, and electron microscopic assessment. S Swedberg B Brown R Sigley T Wight D Gordon S Nicholls, Circulation 1989 80 1726 1736 2688974
8. Permanent vascular access: A nephrologist's view. D Windus, Am J Kidney Dis 1993 21 457 471 8488813
9. Radial artery wall shear stress evaluation in patients with arteriovenous fistula for hemodialysis access. A Remuzzi B Ene-Iordache L Mosconi S Bruno A Anghileri L Antiga G Remuzzi, Biorheology 2003 40 423 430 12454436
10. Arterial wall shear stress: Observations from the bench to the bedside. J Paszkowiak A Dardik, Vasc Endovascular Surg 2003 37 47 57 10.1177/ 153857440303700107 12577139
11. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. P Roy-Chaudhury B Kelly M Miller A Reaves J Armstrong N Nanayakkara S Heffelfinger, Kidney Int 2001 59 2325 2334 11380837
12. Is AV fistula patency associated with angiotensin-converting enzyme (ACE) polymorphism and ACE inhibitor intake? G Heine C Ulrich H Kohler M Girndt, Am J Nephrol 2004 24 461 468 10.1159/000080464 15331890
13. Increasing arteriovenous fistulas in hemodialysis patients: Problems and solutions. M Allon M Robbin, Kidney Int 2002 62 1109 1124 10.1111/j.1523-1755. 2002.kid551.x 12234281
14. Intimal hyperplasia in vascular grafts. M Lemson J Tordoir M Daemen P Kitslaar, Eur J Vasc Endovasc Surg 2000 19 336 350 10.1053/ejvs.1999.1040 10801366
15. Transforming growth factor β1 genotype polymorphisms determine AV fistula patency in hemodialysis. G Heine C Ulrich U Sester M Sester K Köhler M Girndt, Kidney Int 2003 64 1101 1107 10.1046/j.1523-1755.2003. 00176.x 12911563
16. Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. M Weiss V Scivittaro J Anderson, Am J Kidney Dis 2001 37 970 980 11325679
17. Leukocyte-polytetra-fluoroethylene interaction enhances proliferation of vascular smooth muscle cells via tumor necrosis factor-α secretion. J Mattana C Effiong A Kapasi P Singhal, Kidney Int 1997 52 1478 1485 10.1038/ki.1997.478 9407493
18. The effect of growth factors, cytokines, and extracellular matrix proteins on fibronectin production in human vascular smooth muscle cells. T Kaiura H Itoh S Kubaska T McCaffrey B Liu K Kent, J Vasc Surg 2000 31 577 584 10.1016/S0741-5214(00)90320-3 10709072
19. Transforming growth factor beta in tissue fibrosis. W Border N Noble, N Engl J Med 1994 342 1350 1358
20. How do A-V fistula lose function? The roles of haemodynamics, vascular remodelling, and intimal hyperplasia. C Hehrlein, Nephrol Dial Transplant 1994 10 1287 1290
21. Endothelin-1 is a mediator of intimal hyperplasia in organ culture of human saphenous vein. I Masood K Porter N London, Br J Surg 1997 87 499 503 10.1002/bjs.1800840418
22. Hemodynamic and morphologic features of ateriovenous angioaccess loop grafts. J Zamora Z Gao BG Weilbaecher L Navarro C Yves C Hita G Noon, Trans Am Soc Artif Intern Organs 1985 31 119 123 3837427
23. Redox mediated activation of latent transforming growth factor-beta 1. M Barcellos-Hoff T Dix, Mol Endocrinol 1996 10 1077 1083 10.1210/me.10.9.1077 8885242
24. The lipid peroxidation end product 4-hydrox-2, 3-nonenol up-regulates transforming growth factor β1 expression in the macrophage lineage: A link between oxidative injury and fibrosclerosis. G Leonarduzzi A Scavazza F Biasi E Chiarpotto S Camandola S Vogl R Dargel G Poli, FASEB J 1997 11 851 857 9285483
25. LDL-platelet interaction under oxidative stress induces macrophage foam cell formation. M Aviram, Thromb Haemost 1995 74 560 564 8578524
26. Pathophysiology of endothelin in the cardiovascular system. T Miyauchi T Masaki, Annu Rev Physiol 1999 61 391 415 10.1146/annurev.physiol.61.1.391 10099694
27. Modification of venous end of dialysis grafts: an attempt to reduce neointimal hyperplasia. A Coulson J Moya, Dialysis Transplant 2000 29 10 17
28. The role of vascular and structural remodeling. V Dzau, Cardiovascular Medicine New York: Churchill-Livingstone, Willerson J, Cohn J, 2 1995 1067 1079
29. Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. S Stracke K Konner I Kostlin R Friedl P Jehle V Hombach F Keller J Waltenberger, Kidney Int 2002 61 1011 1019 10.1046/j.1523-1755.2002.00191.x 11849456
30. Does the arteriovenous fistula in chronic hemodialysis patients stimulate endothelin-1 release? M Wilkie N Khandan-Nia A Ghatei S Bloom M Raftery J Cunningham, Nephrol Dial Transplant 1992 7 1019 21 1331876
31. Expression of basic fibroblast growth factor and its receptor by fibroblast, macrophages and mast cells in hypertrophic scar. S Akimoto O Ishikawa C Iijima Y Miyachi, European Journal of Dermatology 1999 9 5 357 362 10417437
32. Dependence of neurones on astrocytes in a coculture system renders neurones sensitive to tranforming growth factor beta1-induced glutamate toxicity. D Brown, J Neurochemistry 1999 72 943 953 10.1046/j.1471-4159.1999. 0720943.x
33. Bone growth factors: Potential for use as an osseointegration enhancement techique (OIT). S Koka J Vance G Maze, 1995 http://focus.hms.harvard.edu/2000/ Sep15_2000/ophthalmology.html
34. A low affinity, low molecular weight endothelin-A receptor present in neonatal rat heart. E Woodcock S Land R Andrews, Clin Exp Pharmacol Physiol 1993 20 331 334 10.1111/j.1440-1681.1993.tb01697.x 8324919
35. Mathematical modeling of spatio-temporal phenomena in tumor immunology. M Chaplain A Matzavinos, Tutorials in Mathematical Biosciences III: Cell Cycle, Proliferation, and Cancer New York: Springer, Friedman A, 2006 131 186
36. A mechanochemical model for adult wound contraction and the permanence of the contracted tissue displacement profile. L Olsen J Sherratt P Maini, J Theor Biol 1995 177 113 128 10.1006/jtbi.1995.0230 8558902
37. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. S Stacker K Stenvers C Caesar A Vitali T Domagala E Nice S Roufail R Simpson R Moritz T Karpanen K Alitalo M Achen, J Biol Chem 1999 274 32127 33216 10.1074/jbc.274.45.32127 10542248
38. Isolated lymphatic endothelial cells transduce growth, survival, and migratory signals via the VEGF-C/D receptor VEGFR-3. T Mäkinen T Veikkola S Mustjoki T Karpanen B Catimel E Nice L Wise A Mercer H Kowalski D Kerjaschki S Stacker M Achen K Alitalo, EMBO J 2001 20 4762 4773 11532940 10.1093/emboj/20.17.4762
39. The specificity of receptor binding by vascular endothelial growth factor-D is different in mouse and man. M Baldwin B Catimel E Nice S Roufail N Hall K Stenvers M Karkkainen K Alitalo S Stacker M Achen, J Biol Chem 2001 276 19166 19171 10.1074/jbc.M100097200 11279005
40. Chemoattractants and growth factors. G Grotendorst, Wound Healing: Biochemical and Clinical Aspects Philadelphia: Saunders, Cohen I, Diegelmann R, Lindblad W, 1992 237 246